Alf Hamann

Title: Alf Hamann: Innovator in Regulatory T Cell Detection

Introduction

Alf Hamann is a notable inventor based in Eichwalde, Germany. He has made significant contributions to the field of immunology, particularly in the detection and quality control of regulatory T cells. His innovative work has implications for various medical applications, enhancing our understanding of immune responses.

Latest Patents

Alf Hamann holds a patent for a method related to the detection and quality control of regulatory T cells through DNA-methylation analysis of the Foxp3 gene. This invention provides an in vitro method for identifying FoxP3-positive regulatory T cells, specifically CD25CD4 regulatory T cells of mammals. The method involves analyzing the methylation status of at least one CpG position in the Foxp3 gene or its orthologous or paralogous genes. Additionally, the invention includes a kit designed for performing these methods, along with respective uses.

Career Highlights

Throughout his career, Alf Hamann has worked with prominent organizations, including Epiontis GmbH and Charité - Universitätsmedizin Berlin. His experience in these institutions has allowed him to collaborate with leading experts in the field, further advancing his research and innovations.

Collaborations

Alf Hamann has collaborated with notable colleagues such as Jochen Huehn and Stefan Floess. These partnerships have contributed to the development of his patented methods and have fostered advancements in the study of regulatory T cells.

Conclusion

Alf Hamann's contributions to the field of immunology through his innovative patent demonstrate his commitment to advancing medical science. His work in the detection and quality control of regulatory T cells is a testament to the importance of innovation in healthcare.